Schedule 13G ownership disclosure

Madrigal Pharmaceuticals Inc

Security class unavailable · CUSIP: 558868105

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,123,061
Percent of class
6.5700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-018021
Form type
SC 13G/A
Filer
MADRIGAL PHARMACEUTICALS, INC.
CIK
CIK 1157601
Filed
Feb 10, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub